These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19592635)

  • 1. Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002.
    Herder C; Zierer A; Koenig W; Roden M; Meisinger C; Thorand B
    Diabetes Care; 2009 Oct; 32(10):1921-3. PubMed ID: 19592635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events.
    Herder C; Peeters W; Zierer A; de Kleijn DP; Moll FL; Karakas M; Roden M; Meisinger C; Thorand B; Pasterkamp G; Koenig W
    Eur J Clin Invest; 2012 Mar; 42(3):329-37. PubMed ID: 21950567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.
    Herder C; Baumert J; Thorand B; Koenig W; de Jager W; Meisinger C; Illig T; Martin S; Kolb H
    Diabetologia; 2006 May; 49(5):921-9. PubMed ID: 16532324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
    Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.
    Herder C; Baumert J; Zierer A; Roden M; Meisinger C; Karakas M; Chambless L; Rathmann W; Peters A; Koenig W; Thorand B
    PLoS One; 2011; 6(6):e19852. PubMed ID: 21674000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis.
    Sujana C; Huth C; Zierer A; Meesters S; Sudduth-Klinger J; Koenig W; Herder C; Peters A; Thorand B
    Eur J Endocrinol; 2018 Apr; 178(4):389-398. PubMed ID: 29439057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study.
    Thorand B; Zierer A; Huth C; Linseisen J; Meisinger C; Roden M; Peters A; Koenig W; Herder C
    Diabetes Care; 2011 Oct; 34(10):2320-2. PubMed ID: 21873558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.
    Thorand B; Kolb H; Baumert J; Koenig W; Chambless L; Meisinger C; Illig T; Martin S; Herder C
    Diabetes; 2005 Oct; 54(10):2932-8. PubMed ID: 16186395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
    Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
    Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.
    Herder C; Klopp N; Baumert J; Müller M; Khuseyinova N; Meisinger C; Martin S; Illig T; Koenig W; Thorand B
    Diabetologia; 2008 Feb; 51(2):276-84. PubMed ID: 17712545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Herder C; Illig T; Baumert J; Müller M; Klopp N; Khuseyinova N; Meisinger C; Poschen U; Martin S; Koenig W; Thorand B
    Eur J Endocrinol; 2008 May; 158(5):R1-5. PubMed ID: 18426815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
    Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus.
    Yener S; Demir T; Akinci B; Bayraktar F; Kebapcilar L; Ozcan MA; Biberoglu S; Yesil S
    Diabetes Res Clin Pract; 2007 May; 76(2):193-8. PubMed ID: 17014924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults.
    Lin Y; Nakachi K; Ito Y; Kikuchi S; Tamakoshi A; Yagyu K; Watanabe Y; Inaba Y; Kazuo Tajima ;
    Dis Markers; 2009; 27(1):23-8. PubMed ID: 19822955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor structural social support is associated with an increased risk of Type 2 diabetes mellitus: findings from the MONICA/KORA Augsburg cohort study.
    Altevers J; Lukaschek K; Baumert J; Kruse J; Meisinger C; Emeny RT; Ladwig KH
    Diabet Med; 2016 Jan; 33(1):47-54. PubMed ID: 26331457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-1998.
    Thorand B; Baumert J; Herder C; Meisinger C; Koenig W
    Diabetologia; 2007 Mar; 50(3):545-8. PubMed ID: 17195062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
    Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
    Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus.
    Wong MG; Perkovic V; Woodward M; Chalmers J; Li Q; Hillis GS; Yaghobian Azari D; Jun M; Poulter N; Hamet P; Williams B; Neal B; Mancia G; Cooper M; Pollock CA
    Kidney Int; 2013 Feb; 83(2):278-84. PubMed ID: 23235570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation for TGF-β1 expression in type 2 diabetes and protective effects of TGF-β1 on osteoblasts under high glucose environment.
    Wang WD; Cheng BZ; Kang WB; Zheng RW; Cai YL; Wang XJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6500-6506. PubMed ID: 30338820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
    Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S135-9. PubMed ID: 26559756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.